@joseruizlab.bsky.social
đ¤ 149
đĽ 108
đ 44
đ¨ PhD Opportunity @UMU! Join a 4-year funded FPI project on light-activated metallodrugs for cancer therapy. Start: Jan 2026 | Deadline: Oct 15, 2025 đ§ Contact:
[email protected]
đ PDF attached â official link coming soon!
#PhDOffer
#CancerResearch
#FPIContract
#UMU
#ChemistryJobs
7 days ago
0
6
4
Honored to give an invited talk at
@isbomc25.bsky.social
in Paris on iridium-based photodynamic therapy for cancer. Huge thanks to the organizers for the opportunity!
@gassergroup.bsky.social
about 1 month ago
0
22
4
Happy to see the new paper from our great collaboration with
@kargesgroup.bsky.social
on
#PDT
,
#Iridium
and
#HSA
conjugation! Thanks to all-coauthors & also to
@ruhr-uni-bochum.de
, @UMU & @AEI
add a skeleton here at some point
2 months ago
1
9
1
Nice cover in Inorg Chem Front. Thank you to the great designers. Great collaboration with @MarchanLab_UM.
add a skeleton here at some point
3 months ago
0
5
0
Glad to share our last studies in collaboration with Viktor Brabec. Photoactivatable Ir(III) Compound Penetrates the Blood-Brain Barrier in 3D Spheroidal and Advanced 3D Organoid Models of Inherently Resistant and Aggressive Brain Tumors | ACS Pharmacol & Transl Science
pubs.acs.org/doi/full/10....
loading . . .
Photoactivatable Cyclometalated Ir(III) Compound Penetrates the Blood-Brain Barrier in 3D Spheroidal and Advanced 3D Organoid Models of Inherently Resistant and Aggressive Brain Tumors
The blood-brain barrier represents a significant challenge in delivering anticancer drugs for glioblastoma treatment. The study investigates the potential of a series of octahedral photoactivatable cyclometalated iridium complexes (Ir1âIr10) with the general formula [Ir(ttpy)(Câ§N)Cl]PF6 as photoactivated therapy candidates for the treatment of this aggressive tumor. These complexes, which include the terdentate ligand 4â˛-(p-tolyl)-2,2â˛:6â˛,2âł-terpyridine (ttpy), and a Câ§N ligand based on the deprotonated 2-arylbenzimidazole backbone, were tested on human glioblastoma using 2D cell cultures and 3D spheroidal models, including a fusion system comprising cerebral organoids from nonmalignant human-induced pluripotent stem cells and spheroids derived from malignant brain cells. The iridium complexes catalyze NADH photooxidation and photogenerate 1O2 and/or â˘OH under blue light irradiation. Blood-brain barrier penetration was assessed using various in vitro models. The complex Ir4, containing deprotonated methyl 1-butyl-2-phenylbenzimidazolecarboxylate, shows promise for targeted therapy of resistant brain tumors when photoactivated with blue light. Ir4 induces rapid and sustained ROS-mediated cytotoxicity and selectively accumulates in tumor tissue. This suggests its potential for fluorescently guided-PDT cooperative resection of glioblastoma. Notably, Ir4 significantly reduces glioblastoma growth even under dark conditions compared to conventional Temozolomide treatment without affecting healthy brain tissue.
https://pubs.acs.org/doi/full/10.1021/acsptsci.5c00145
3 months ago
1
15
5
A truly special moment at the @aeec_murcia Gala 2025. Deeply honored to receive this recognition for our research on
#metals
in medicine and
#photodynamictherapy
in the fight against
#Cancer
. Grateful to @AECC, @UMU,
@ageinves.bsky.social
, @IMIB_RMurcia, @FundacionSeneca, & all our collaborators.
5 months ago
2
8
0
Glad to participate in this interesting review in
@inorgchemfront.rsc.org
. Thank you to all the co-authors. Great collaboration with @MarchanLab_UB.
add a skeleton here at some point
5 months ago
0
8
2
Nice to see our recent article on the Front cover- now published in Inorganic Chemistry Frontiers.
doi.org/10.1039/D4QI...
. Great collaboration with @MarchanLab_UB.
5 months ago
0
12
3
It was a great pleasure to present our latest results onPDT at the excellent 19th Ferrocene Colloquium at RUB University (Bochum, Germany). Many thanks to the organizers, @NMNLab &
@viktoriagessner.bsky.social
for the invitation. Thank you also
@kargesgroup.bsky.social
for the nice collaboration.
6 months ago
0
10
1
Congratulations to Dana Josa and her PhD supervisors! Thrilled to have been part of the PhD jury at The University of Barcelona.
add a skeleton here at some point
6 months ago
0
4
0
reposted by
Gasser Group
7 months ago
Congrats to Apolline, Corentin & Suai for their review on the synthetic strategies for the incorporation of metallocenes into anti-infective scaffolds just accepted in
@chemsocrev.rsc.org
doi.org/10.1039/D4CS...
@cariouk.bsky.social
@chimieparistechpsl.bsky.social
1
27
7
reposted by
Oliver Wenger
6 months ago
A simple guide to the design of metal complexes in luminescence and photoredox catalysis. With Giacomo Morselli and Christian Reber in JACS
@jacs.acspublications.org
pubs.acs.org/doi/10.1021/...
loading . . .
Molecular Design Principles for Photoactive Transition Metal Complexes: A Guide for âPhoto-Motivatedâ Chemists
Luminescence and photochemistry involve electronically excited states that are inherently unstable and therefore spontaneously decay to electronic ground states, in most cases by nonradiative energy release that generates heat. This energy dissipation can occur on a time scale of 100 fs (âź10â13 s) and usually needs to be slowed down to at least the nanosecond (âź10â9 s) time scale for luminescence and intermolecular photochemistry to occur. This is a challenging task with many different factors to consider. An alternative emerging strategy is to target dissociative excited states that lead to metalâligand bond homolysis on the subnanosecond time scale to access synthetically useful radicals. Based on a thorough review at the most recent advances in the field, this article aims to provide a concise guide to obtaining luminescent and photochemically useful coordination compounds with d-block elements. We hope to encourage âphoto-motivatedâ chemists who have been reluctant to apply their synthetic and other knowledge to photophysics and photochemistry, and we intend to stimulate new approaches to the synthetic control of excited state behavior.
https://pubs.acs.org/doi/10.1021/jacs.5c02096
0
66
20
reposted by
Universidad de Castilla-La Mancha
6 months ago
La UCLM lamenta el fallecimiento de FĂŠlix JalĂłn SotĂŠs, quien fuera catedrĂĄtico de QuĂmica InorgĂĄnica y director del Instituto Regional de InvestigaciĂłn CientĂfica Aplicada (IRICA) La imagen recoge el homenaje que le dio la Facultad de Ciencias y TecnologĂas QuĂmicas el pasado mes de diciembre.
1
3
3
reposted by
The Babak Lab
6 months ago
Read our paper in
@acsjacs.bsky.social
!
@acs.org
The Babak Lab đ¤ Prof. Ang Wee Han, Prof. Walter Berger and City University of Hong Kong!
#chemsky
loading . . .
1
14
4
Glad to participate in this paper. Great collaboration with
@kargesgroup.bsky.social
congrats
@antoniolinero.bsky.social
& Lisa!
add a skeleton here at some point
6 months ago
0
8
1
Excited to be part of this multidisciplinary paper! Congrats to all co-authors!
add a skeleton here at some point
7 months ago
0
5
1
reposted by
Eduardo Peris
7 months ago
Happy to share this great work by Sebas M.-Vivas and Maca Poyatos
@inam-uji.bsky.social
in
@chemicalscience.rsc.org
. A fluoride-induced redox switchable behaviour of a Pd(II)/(IV) couple.
pubs.rsc.org/en/content/a...
1
26
7
Alba's PhD hesis defense.
7 months ago
0
12
0
Congratulations to Dr. Alba HernĂĄndez for her brilliant thesis defense! We wish you all the best Alba! Many thanks
@lrraurell.bsky.social
& @MarchanLab_UB for your help.
7 months ago
1
11
0
reposted by
Gasser Group
7 months ago
Congrats
@dianamelis.bsky.social
for her article in
@chemicalscience.rsc.org
. We describe the 1st use of bioorthogonal click chemistry with 188Re for radiolabelling of an anti-c-Met VHH NanobodyÂŽ. Great collaboration with the Opsomer/Ooms group
@chimieparistechpsl.bsky.social
doi.org/10.1039/D4SC...
1
45
12
reposted by
The Babak Lab
7 months ago
Our latest publication, "Leveraging Immunogenic Cell Death to Enhance the Immune Response against Malignant Pleural Mesothelioma Tumors" in JACS, showcases the remarkable potential of novel Au(III) complexes to induce long-lasting antitumor immunity. We are all super proud of this achievement đŞ
3
12
7
Excellent news!! Congrats Enrique!
add a skeleton here at some point
7 months ago
2
7
0
reposted by
Albert Gandioso Ubieto
8 months ago
Thrilled to share our
#JACS
paper! Our new Ru(II)-COUBPY photosensitizer (PI >30,000) for hypoxic tumor treatment using red light with in vivo validation!.
@gassergroup.bsky.social
pubs.acs.org/doi/10.1021/...
loading . . .
Ruthenium(II) Polypyridyl Complexes Containing COUBPY Ligands as Potent Photosensitizers for the Efficient Phototherapy of Hypoxic Tumors
Hypoxia, a hallmark of many solid tumors, is linked to increased cancer aggressiveness, metastasis, and resistance to conventional therapies, leading to poor patient outcomes. This challenges the effi...
https://pubs.acs.org/doi/10.1021/jacs.4c15036
3
35
13
reposted by
Eduardo Peris
8 months ago
đ˘ Registration now open for the International School of Organometallic Chemistry 'Marcial Moreno MaĂąas'! Don't miss your chance to attend to this great meeting. Registration will be open until April 30th! We hope to see you here between June 11-13th! đ
sites.google.com/uji.es/isocm...
0
19
11
reposted by
Angelo Frei
8 months ago
We are recruiting for a 30 month 0.7 FTE Postdoc position working on metallo-antifungals as part of the RAFT project.
tinyurl.com/3mtxwx8h
Looking for skilled synthetic (bio)-inorganic chemists! For more details on the project check out
www.jpiamr.eu/projects/raft
and feel free to reach out!
0
8
4
reposted by
8 months ago
My first paper from my time at
@unileiden.bsky.social
is out𼳠Herein we studied various Ru cages for their safety and potential use against brain tumors. Thanks to my co authors Anja and Matthijs for their amazing work and Sylvestre for his input and the great Teamwork
pubs.acs.org/doi/10.1021/...
loading . . .
Toward the Treatment of Glioblastoma Tumors Using Photoactivated Chemotherapy: In Vitro Evaluation of Efficacy and Safety
Glioblastoma multiforme (GBM) is highly aggressive, necessitating new therapies. Photoactivated chemotherapy (PACT) offers a promising approach by activating prodrugs with visible light at the tumor site. This study evaluated the anticancer activity of ruthenium-based PACT compounds in U-87MG glioblastoma cells and their safety in SH-SY5Y neuron-like cells. The compound [3](PF6)2 showed promising light-activated anticancer effects in U-87MG cells, while [1](PF6)2 was inactive, and [2](PF6)2 was nonactivated. Interestingly, in SH-SY5Y cells, light-activated [3](PF6)2 increased cell proliferation, similar to donepezil, without causing cell death. Increased Ca2+ uptake was observed, possibly via interaction with the AMPA receptor, as suggested by docking studies. These findings suggest ruthenium-based PACT compounds may serve as potential treatments for GBM, effectively attacking cancer cells while preserving healthy neuronal cells.
https://pubs.acs.org/doi/10.1021/acsptsci.4c00600
0
5
3
A novel arene osmium(ii) complex as an effective rhabdomyosarcoma cancer stem cell agent - now published in InorgChemFront in collaboration with Viktor Brabec
pubs.rsc.org/en/content/a...
Congrats to all the co-authors.
loading . . .
A novel benzothiazole-1,2,3-triazole-based arene osmium(II) complex as an effective rhabdomyosarcoma cancer stem cell agent
We designed a series of pseudo-octahedral arene Os(ii) complexes (Os1âOs5) with the general formula [(Ρ6-p-cym)Os(BTAT)Cl]+, where BTAT represents chelating N^NⲠligands based on the 1-aryl-4-benzothi...
https://pubs.rsc.org/en/content/articlelanding/2025/qi/d4qi02737j
9 months ago
1
21
7
reposted by
AEBIN - Spanish Association of Bioinorganic Chemistry
9 months ago
Come join us for our biannual meeting in Ciudad Real! More info here:
www.biociudadreal.es
0
13
10
reposted by
Angelo Frei
9 months ago
Our Minireview on the growing field of combinatorial metal complex synthesis is now out!
onlinelibrary.wiley.com/doi/full/10....
loading . . .
HighâThroughput Combinatorial Metal Complex Synthesis
This minireview explores advancements in high-throughput combinatorial synthesis of metal complexes, emphasising their applications in catalysis, drug discovery, and materials science. We highlight v...
https://onlinelibrary.wiley.com/doi/full/10.1002/anie.202420204
0
15
5
reposted by
Gloria Vigueras
9 months ago
đ Starting the year with exciting news! Our Frontier paper is now out in
@daltontrans.bsky.social
đĄBreaking the deep-red light absorption barrier of iridium(iii)-based PSs. đđťhttps://pubs.rsc.org/en/content/articlelanding/2025/dt/d4dt03014a
@joseruizlab.bsky.social
@gassergroup.bsky.social
2
20
10
reposted by
Marcos Palmeira
9 months ago
Delighted to share our
#ChemBioChem
paper on cytotoxic Ruthenium(II) diphosphine complexes and their effect on lung
#cancer
cells. Congrats to all! đđđ
#chemsky
#science
@agenciafapesp.bsky.social
@ufscar.bsky.social
@chemistryeurope.bsky.social
@gassergroup.bsky.social
0
15
4
reposted by
Kevin Cariou
9 months ago
If you like molecular sandwiches and their applications in biology, don't forget to register to the 2025 International Symposium on Bioorganometallic Chemistry that we will host with
@gassergroup.bsky.social
in August in Paris.
isbomc25.sciencesconf.org?lang=en
add a skeleton here at some point
0
11
7
reposted by
Karges Group
9 months ago
Check out our paper in Small about utilizing the Excited Intramolecular ProtonâCoupled Electron Transfer in a Dinuclear Ir(III) Complex for Photodynamic Therapy. Congrats to Maniklal, Julia, Nishith, Gourav and
@nmontesdeocas.bsky.social
!
onlinelibrary.wiley.com/doi/10.1002/...
1
18
3
reposted by
Luca Salassa
10 months ago
Out latest article on ChemCatChem
doi.org/10.1002/cctc...
loading . . .
RedâLight Photocatalytic Activation of Pt(IV) Anticancer Prodrugs Using Methylene Blue
Methylene blue acts as a photocatalyst in the presence of biologically relevant electron donors, enabling red-light conversion of two Pt(IV) complexes into cisplatin and oxaliplatin. Spectroscopy and...
https://doi.org/10.1002/cctc.202401424
1
31
10
reposted by
Karges Group
10 months ago
Check out our article in Dalton Trans. about a Necrosis Inducing Tetranuclear Ru(II)-Re(I) complex for Anticancer Therapy. Congrats to Julia, Eleni, Stephan, and
@nmontesdeocas.bsky.social
!
@ruhr-uni-bochum.de
dx.doi.org/10.1039/D4DT...
0
18
4
reposted by
Gasser Group
10 months ago
Extremely honoured to receive the Cannizzaro-Arnaudon Lectureship 2024 jointly delivered by the Italian and French Chemical Societies. Looking forward to going to Italy next year! Many thanks to all current and previous members of the group. Special mention to
@cariouk.bsky.social
for all his help.
9
64
6
reposted by
Phoebe Glazer
10 months ago
Congrats to
@richardmitchell210.bsky.social
for an excellent study leveraging metabolic analysis! This paper shows how photodynamic therapy photosensitizers and photoactivated chemotherapeutics exhibit distinct bioenergetic profiles - now in Chemical Science (a đ§ľ)
pubs.rsc.org/en/content/a...
loading . . .
Photodynamic therapy photosensitizers and photoactivated chemotherapeutics exhibit distinct bioenergetic profiles to impact ATP metabolism
Energy is essential for all life, and mammalian cells generate and store energy in the form of ATP by mitochondrial (oxidative phosphorylation) and non-mitochondrial (glycolysis) metabolism. These pro...
https://pubs.rsc.org/en/content/articlelanding/2024/sc/d4sc05393a
5
32
9
reposted by
Karges Group
10 months ago
Check out our article in J. Med. Chem.
@acsmedi.bsky.social
about the Combinatorial Synthesis toward the Discovery of Highly Cytotoxic Fe(III) Complexes. Congrats to Felix, Lisa, Zisis, and
@nmontesdeocas.bsky.social
!
@ruhr-uni-bochum.de
pubs.acs.org/doi/10.1021/...
1
34
6
reposted by
Karges Group
10 months ago
Check out our paper in J. Biol. Inorg. Chem.
@springer1842.bsky.social
about the shift of cell death mechanism in primary human neutrophils upon treatment with a Ru(II) polypyridine complex. Great collaboration with the Kruss Group! Congrats Nicolas and Jennifer!
dx.doi.org/10.1007/s007...
1
22
4
Glad to share our recent paper in collaboration with Prof. Brabec, published in JMC. Congrats to all co-authors!
pubs.acs.org/doi/full/10....
loading . . .
A Novel Substituted Benzo[g]quinoxaline-Based Cyclometalated Ru(II) Complex as a Biocompatible Membrane-Targeted PDT Colon Cancer Stem Cell Agent
Herein, we describe and investigate biological activity of three octahedral ruthenium(II) complexes of the type [Ru(Câ§N)(phen)2]+, RuL1âRuL3, containing a Ď-expansive cyclometalating substituted benzo[g]quinoxaline ligand (Câ§N ligand) (phen = 1,10-phenanthroline). Compounds RuL1âRuL3 in cervical, melanoma, and colon human cancer cells exhibit high phototoxicity after irradiation with light (particularly blue), with the phototoxicity index reaching 100 for the complex RuL2 in most sensitive HCT116 cells. RuL2 accumulates in the cellular membranes. If irradiated, it induces lipid peroxidation, likely connected with photoinduced ROS generation. Oxidative damage to the fatty acids leads to the attenuation of the membranes, the activation of caspase 3, and the triggering of the apoptotic pathway, thus implementing membrane-localized photodynamic therapy. RuL2 is the first photoactive ruthenium-based complex capable of killing the hardly treatable colon cancer stem cells, a highly resilient subpopulation within a heterogeneous tumor mass, responsible for tumor recurrence and the metastatic progression of cancer.
https://pubs.acs.org/doi/full/10.1021/acs.jmedchem.4c02357
10 months ago
2
21
5
Congrats Maria!đ
10 months ago
0
0
0
you reached the end!!
feeds!
log in